| ASSET | YEAR | % RETURN |
|---|---|---|
Edgewise Therapeutics (EWTX) | 2021 | -43.41% |
Edgewise Therapeutics (EWTX) | 2022 | -39.23% |
Edgewise Therapeutics (EWTX) | 2023 | 21.56% |
Edgewise Therapeutics (EWTX) | 2024 | 144.28% |
Edgewise Therapeutics (EWTX) | 2025 | -7.23% |
Edgewise Therapeutics (EWTX) | 2026 | 14.75% |
